×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
LS12: How should We Collaborate Together to Enhance Model-Informed Drug Development?
Session Chair(s)
Atsushi Tsukamoto, PhD, MSc
Corporate Officer, Head is Therapeutic Area Strategies
Daiichi Sankyo, United States
Speaker(s)
Takayo Ueno
Takayo Ueno
Bristol Myers Squibb, Japan
Director, Clinical Pharmacology Strategy
Norisuke Kawai, PhD
Norisuke Kawai, PhD
Pfizer R&D Japan G.K., Japan
Senior Director, Biometrics & Data Management
Daisuke Iwata
Daisuke Iwata
Pharmaceuticals and Medical Devices Agency, Japan
Office of Advanced Evaluation with Electronic Data
Have an account?